Adjunctive N -Acetyl- l -Cysteine in Treatment of Murine Pneumococcal Meningitis
Open Access
- 1 October 2013
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 57 (10) , 4825-4830
Abstract
Despite antibiotic therapy, acute and long-term complications are still frequent in pneumococcal meningitis. One important trigger of these complications is oxidative stress, and adjunctive antioxidant treatment with N-acetyl-l-cysteine was suggested to be protective in experimental pneumococcal meningitis. However, studies of effects on neurological long-term sequelae are limited. Here, we investigated the impact of adjunctive N-acetyl-l-cysteine on long-term neurological deficits in a mouse model of meningitis. C57BL/6 mice were intracisternally infected with Streptococcus pneumoniae. Eighteen hours after infection, mice were treated with a combination of ceftriaxone and placebo or ceftriaxone and N-acetyl-l-cysteine, respectively. Two weeks after infection, neurologic deficits were assessed using a clinical score, an open field test (explorative activity), a t-maze test (memory function), and auditory brain stem responses (hearing loss). Furthermore, cochlear histomorphological correlates of hearing loss were assessed. Adjunctive N-acetyl-l-cysteine reduced hearing loss after pneumococcal meningitis, but the effect was minor. There was no significant benefit of adjunctive N-acetyl-l-cysteine treatment in regard to other long-term complications of pneumococcal meningitis. Cochlear morphological correlates of meningitis-associated hearing loss were not reduced by adjunctive N-acetyl-l-cysteine. In conclusion, adjunctive therapy with N-acetyl-l-cysteine at a dosage of 300 mg/kg of body weight intraperitoneally for 4 days reduced hearing loss but not other neurologic deficits after pneumococcal meningitis in mice. These results make a clinical therapeutic benefit of N-acetyl-l-cysteine in the treatment of patients with pneumococcal meningitis questionable.Keywords
This publication has 47 references indexed in Scilit:
- The ROS Scavenger, NAC, Regulates Hepatic Vα14iNKT Cells Signaling during Fas mAb-Dependent Fulminant Liver FailurePLOS ONE, 2012
- Drug-induced liver injuryCurrent Opinion in Gastroenterology, 2012
- Adult neurogenesis in mammals – a theme with many variationsEuropean Journal of Neuroscience, 2011
- Reduced spiral ganglion neuronal loss by adjunctive neurotrophin-3 in experimental pneumococcal meningitisJournal of Neuroinflammation, 2011
- Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial MeningitisClinical Microbiology Reviews, 2010
- Routes, dynamics, and correlates of cochlear inflammation in terminal and recovering experimental meningitisThe Laryngoscope, 2009
- MyD88‐Dependent Immune Response Contributes to Hearing Loss in Experimental Pneumococcal MeningitisThe Journal of Infectious Diseases, 2007
- MyD88 is required for mounting a robust host immune response to Streptococcus pneumoniae in the CNSBrain, 2004
- Oxidative stress in brain during experimental bacterial meningitis: differential effects of α-phenyl-tert-butyl nitrone and N-acetylcysteine treatmentFree Radical Biology and Medicine, 2001
- Effects of Clinically Used Antioxidants in Experimental Pneumococcal MeningitisThe Journal of Infectious Diseases, 2000